SILO PHARMA, INC. Cost of Goods and Services Sold
SILO PHARMA, INC. (SILO) reported Cost of Goods and Services Sold of $176.13 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-05-17.
Discontinued › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2021-05-17
- SILO PHARMA, INC. cost of goods and services sold for the quarter ending 2020-12-31 was $145.26K, a 431.99% increase year-over-year.
- SILO PHARMA, INC. cost of goods and services sold for the quarter ending 2020-09-30 was $29.45K, a 35813.41% increase year-over-year.
- SILO PHARMA, INC. cost of goods and services sold for the quarter ending 2020-06-30 was $1.33K.
- SILO PHARMA, INC. cost of goods and services sold for the quarter ending 2020-03-31 was $84.00.
- SILO PHARMA, INC. cost of goods and services sold for fiscal 2020 was $176.13K, a 543.10% increase from fiscal 2019.
- SILO PHARMA, INC. cost of goods and services sold for fiscal 2019 was $27.39K.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2020-12-31 | $145.26K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | $174.71K derived: sum of 2 quarters · filed 2021-05-17 | $176.04K derived: sum of 3 quarters · filed 2021-05-17 | $176.13K 10-K/A · filed 2021-05-17 |
| 2020-09-30 | $29.45K 10-Q · filed 2020-11-05 | $30.78K derived: sum of 2 quarters · filed 2020-11-05 | $30.87K 10-Q · filed 2020-11-05 | $58.17K derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-06-30 | $1.33K 10-Q · filed 2020-08-14 | $1.42K 10-Q · filed 2020-08-14 | $28.72K derived: sum of 3 quarters · filed 2021-05-17 | $28.80K derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-03-31 | $84.00 10-Q · filed 2020-05-12 | $27.39K derived: sum of 2 quarters · filed 2021-05-17 | $27.47K derived: sum of 3 quarters · filed 2021-05-17 | |
| 2019-12-31 | $27.30K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | $27.39K derived: sum of 2 quarters · filed 2021-05-17 | $27.39K 10-K/A · filed 2021-05-17 | |
| 2019-09-30 | $82.00 10-Q · filed 2020-11-05 | $82.00 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |